phillip le retweeted
Faced with an urgency to start therapy for newly diagnosed lung cancer, how do we encourage colleagues and patients to wait for biomarker results? Advice from patient advocate Aurora Lucas & Drs. Mark Kris & @TurgemanIlit in this @IASLC podcast episode.
iaslc.org/iaslc-news/lung-ca…
phillip le retweeted
More data showing the importance of *waiting* for NGS results before starting NSCLC therapy whenever possible!
Retrospective analysis @JCOOP_ASCO show that when treatment of driver+ NSCLC before biomarker results is associated with inferior survival.
ascopubs.org/doi/abs/10.1200…
phillip le retweeted
Looking good @UCSanDiego! Our own Geisel Library constructed from Legos @LEGOLAND_CA
phillip le retweeted
Great chart.
Caution that we don't really have much data on death from any trials that we've seen. A lot of optimistic choices here. (70%, not 62%, for AZ; 60%, not 50%, for NVAX; one case of possible severe disease in a PFE vaccine recipient.)
Okay, took me a long time to make this table (icons and everything) so please appreciate column 6. What protects from severe disease? T-cells! See this lovely article: ncbi.nlm.nih.gov/pmc/article…
If virus totally toothless, defanged (Twilight references), vaccinated safe.
phillip le retweeted
Illumina gets CDC backing to track emergence of new COVID-19 strains seekingalpha.com/news/365011…
phillip le retweeted
A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines, from @HelenBranswell. statnews.com/2020/12/19/a-si…
Proud to have started my science career with you @joann_trejo !
This Post is from an account that no longer exists. Learn more
phillip le retweeted
"Less that 20% of cancers in the US are detected by screening. They're detected by symptoms, when it's too late."
Bert Vogelstein, explaining the need for cancer blood tests. #STATNews
Proud to have contributed to this!
Excited about the new TSO 500 releases enabling better, faster, more scalable comprehensive genomic profiling of tumors through automation, ~10x faster data analysis and pipeline enhancements including MSI sensitivity for immuno-onc., and tumor fraction metric (MSAF).
phillip le retweeted
Really Fun Project leads to a Really Great NEW Product:
Illumina and its partner, venture capital-backed IDbyDNA, are introducing a new test that could be an early warning system for the next epidemic bloomberg.com/news/articles/… via @business
phillip le retweeted
Here we go! Training and first validation run! @illumina @microbemagic1 @reidprentice @KellyHoon1 @HeatherLoughton #COVIDSeq #staphb
phillip le retweeted
Please join us next Wednesday and Thursday morning (Oct 7th and 8th) for a Virtual Single Cell event: hear insights from experts on experimental design, tissue prep, QC & data visualization techniques.
Register here for this #VirtualSingleCell event: lnkd.in/d6tVf_C
phillip le retweeted
Don’t get us wrong, what we eat is super important, but when we eat is the determining factor!
@drjasonfung’s newest blog shares key insights about calories, what we eat, and when we eat.
Read ‘A Calorie is a Calorie, but that’s not the right question’: thefastingmethod.com/are_all…
phillip le retweeted
The multi-cancer early detection test from @GRAILbio is truly transformational, and together we’ll ensure the full realization of next generation sequencing into clinical care.
We are excited to announce our agreement to acquire @GRAILbio, the company detecting cancer early with a simple blood test.
Beating cancer begins with finding it. Together we are poised to transform cancer detection.
illumina.com/company/news-ce…
phillip le retweeted
Illumina’s participation in NIH’s RADx program and our development of a COVID testing service reflects our commitment to improve human health by unlocking the power of the genome. lnkd.in/dG52K6b
phillip le retweeted
THINK LIKE AN EPIDEMIOLOGIST:
What does it mean that the median age of new cases is dropping in some areas? I see three possible explanations, not all good. A thread on how to distinguish between them. 1/10
(Figure h/t @ScottGottliebMD)
phillip le retweeted
This is scary. 50% of asymptomatic SARS-CoV-2 patients had abnormal lung CT scans.
Asymptomatics with #COVID19: 3 new publications today @TheLancetInfDis + @NEJM
Diamond Princess-> Japan & Hong Kong
thelancet.com/action/showPdf…
thelancet.com/journals/lanin…
xitter.cf/EricTopol/status/12714…
Asymptomatic persisted in >50%; mostly older age predicts; but 50% w/ abnormal CT scans
phillip le retweeted
COVIDSeq is the first step toward leveraging the scale and performance of next-generation sequencing to expand #COVID19 testing capabilities.
illumina.com/company/news-ce…




























